Old Logo.png
Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million
October 28, 2020 21:55 ET | Cancer Genetics, Inc.
Rutherford, N.J., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics”), a leader in drug discovery and preclinical oncology and immuno-oncology services,...